The novel NF-κB inhibitor DHMEQ synergizes with celecoxib to exert antitumor effects on human liver cancer cells by a ROS-dependent mechanism.

[1]  Verena Jendrossek,et al.  Targeting apoptosis pathways by Celecoxib in cancer. , 2013, Cancer letters.

[2]  J. McCubrey,et al.  COX-2-dependent and COX-2-independent mode of action of celecoxib in human liver cancer cells. , 2011, Omics : a journal of integrative biology.

[3]  Michael J Morgan,et al.  Crosstalk of reactive oxygen species and NF-κB signaling , 2011, Cell Research.

[4]  Wei Wang,et al.  Combined Inhibitory Effects of Celecoxib and Fluvastatin on the Growth of Human Hepatocellular Carcinoma Xenografts in Nude Mice , 2010, The Journal of international medical research.

[5]  P. Fisher,et al.  Vorinostat and sorafenib increase CD95 activation in gastrointestinal tumor cells through a Ca(2+)-de novo ceramide-PP2A-reactive oxygen species-dependent signaling pathway. , 2010, Cancer research.

[6]  P. Fisher,et al.  17-Allylamino-17-Demethoxygeldanamycin and MEK1/2 Inhibitors Kill GI Tumor Cells via Ca2+-Dependent Suppression of GRP78/BiP and Induction of Ceramide and Reactive Oxygen Species , 2010, Molecular Cancer Therapeutics.

[7]  J. McCubrey,et al.  Novel combination of Celecoxib and proteasome inhibitor MG132 provides synergistic antiproliferative and proapoptotic effects in human liver tumor cells , 2010, Cell cycle.

[8]  A. Schönthal,et al.  Enhanced killing of chemo-resistant breast cancer cells via controlled aggravation of ER stress. , 2009, Cancer letters.

[9]  J. McCubrey,et al.  Antitumor Effects of Dehydroxymethylepoxyquinomicin, a Novel Nuclear Factor-κB Inhibitor, in Human Liver Cancer Cells Are Mediated through a Reactive Oxygen Species-Dependent Mechanism , 2009, Molecular Pharmacology.

[10]  T. Kasahara,et al.  Celecoxib potently inhibits TNFalpha-induced nuclear translocation and activation of NF-kappaB. , 2008, Biochemical pharmacology.

[11]  M. Kitamura,et al.  Induction of apoptosis by cigarette smoke via ROS-dependent endoplasmic reticulum stress and CCAAT/enhancer-binding protein-homologous protein (CHOP). , 2008, Free radical biology & medicine.

[12]  E. Reddy,et al.  Celecoxib and a novel COX-2 inhibitor ON09310 upregulate death receptor 5 expression via GADD153/CHOP , 2008, Oncogene.

[13]  R. Meacham,et al.  Oxidative stress is inherent in prostate cancer cells and is required for aggressive phenotype. , 2008, Cancer research.

[14]  M. Kitamura,et al.  Involvement of Selective Reactive Oxygen Species Upstream of Proapoptotic Branches of Unfolded Protein Response* , 2008, Journal of Biological Chemistry.

[15]  K. Oguchi,et al.  Interaction between caspase-8 activation and endoplasmic reticulum stress in glycochenodeoxycholic acid-induced apoptotic HepG2 cells. , 2007, Toxicology.

[16]  M. Cervello,et al.  Potentiation of the antitumor effects of both selective cyclooxygenase-1 and cyclooxygenase-2 inhibitors in human hepatic cancer cells by inhibition of the MEK/ERK pathway , 2007, Cancer biology & therapy.

[17]  J. Uddin,et al.  Calcium-activated endoplasmic reticulum stress as a major component of tumor cell death induced by 2,5-dimethyl-celecoxib, a non-coxib analogue of celecoxib , 2007, Molecular Cancer Therapeutics.

[18]  H. Nakamura,et al.  Tumor-targeted induction of oxystress for cancer therapy , 2007, Journal of drug targeting.

[19]  Y. Takeda,et al.  Role of the Fas/FasL pathway in combination therapy with interferon-alpha and fluorouracil against hepatocellular carcinoma in vitro. , 2007, Journal of hepatology.

[20]  B. Aggarwal,et al.  Inflammation and cancer: how hot is the link? , 2006, Biochemical pharmacology.

[21]  K. Eguchi,et al.  DHMEQ, a novel NF-kappaB inhibitor, induces apoptosis and cell-cycle arrest in human hepatoma cells. , 2006, International journal of oncology.

[22]  C. Trautwein,et al.  Cyclooxygenase-2 inhibition induces apoptosis signaling via death receptors and mitochondria in hepatocellular carcinoma. , 2006, Cancer research.

[23]  J. Uddin,et al.  Downregulation of survivin expression and concomitant induction of apoptosis by celecoxib and its non-cyclooxygenase-2-inhibitory analog, dimethyl-celecoxib (DMC), in tumor cells in vitro and in vivo , 2006, Molecular Cancer.

[24]  B. Gastman,et al.  Interrelated Roles for Mcl-1 and BIM in Regulation of TRAIL-mediated Mitochondrial Apoptosis* , 2006, Journal of Biological Chemistry.

[25]  P. Poma,et al.  Antitumor effects of the novel NF-kappaB inhibitor dehydroxymethyl-epoxyquinomicin on human hepatic cancer cells: analysis of synergy with cisplatin and of possible correlation with inhibition of pro-survival genes and IL-6 production. , 2006, International journal of oncology.

[26]  Amy S. Lee,et al.  Stress induction of GRP78/BiP and its role in cancer. , 2006, Current molecular medicine.

[27]  P. Galle,et al.  Mcl-1 is an anti-apoptotic factor for human hepatocellular carcinoma. , 2006, International journal of oncology.

[28]  H. Hayashi,et al.  TRB3, a novel ER stress‐inducible gene, is induced via ATF4–CHOP pathway and is involved in cell death , 2005, The EMBO journal.

[29]  P. Poma,et al.  Induction of Apoptosis and Inhibition of Cell Growth in Human Hepatocellular Carcinoma Cells by COX‐2 Inhibitors , 2004, Annals of the New York Academy of Sciences.

[30]  M. Labbozzetta,et al.  Expression of WISPs and of Their Novel Alternative Variants in Human Hepatocellular Carcinoma Cells , 2004, Annals of the New York Academy of Sciences.

[31]  H. Namba,et al.  Induction of Thyroid Cancer Cell Apoptosis by a Novel Nuclear Factor κB Inhibitor, Dehydroxymethylepoxyquinomicin , 2004, Clinical Cancer Research.

[32]  K. Umezawa,et al.  Preparation and biological activities of optically active dehydroxymethylepoxyquinomicin, a novel NF-κB inhibitor , 2004 .

[33]  Patrick Dumont,et al.  Mitochondrial p53 activates Bak and causes disruption of a Bak–Mcl1 complex , 2004, Nature Cell Biology.

[34]  A. Sirica,et al.  Celecoxib‐induced apoptosis in rat cholangiocarcinoma cells mediated by Akt inactivation and Bax translocation , 2004, Hepatology.

[35]  Yanan Yang,et al.  Caspase-dependent apoptosis and -independent poly(ADP-ribose) polymerase cleavage induced by transforming growth factor beta1. , 2004, The international journal of biochemistry & cell biology.

[36]  C. Chou,et al.  DNA-damaging reagents induce apoptosis through reactive oxygen species-dependent Fas aggregation , 2003, Oncogene.

[37]  P. Schirmacher,et al.  Proapoptotic and antiproliferative potential of selective cyclooxygenase‐2 inhibitors in human liver tumor cells , 2002, Hepatology.

[38]  Ping Liu,et al.  Activation of NF-kappaB, AP-1 and STAT transcription factors is a frequent and early event in human hepatocellular carcinomas , 2002 .

[39]  Pan‐Chyr Yang,et al.  Cyclooxygenase-2 Inducing Mcl-1-dependent Survival Mechanism in Human Lung Adenocarcinoma CL1.0 Cells , 2001, The Journal of Biological Chemistry.

[40]  C. Ong,et al.  Role of intracellular thiol depletion, mitochondrial dysfunction and reactive oxygen species in Salvia miltiorrhiza-induced apoptosis in human hepatoma HepG2 cells. , 2001, Life sciences.

[41]  M. Hengartner.  The biochemistry of apoptosis , 2000, Nature.

[42]  Guido Kroemer,et al.  Mitochondrial control of cell death , 2000, Nature Medicine.

[43]  A. Bowie,et al.  Oxidative stress and nuclear factor-kappaB activation: a reassessment of the evidence in the light of recent discoveries. , 2000, Biochemical pharmacology.

[44]  Junying Yuan,et al.  Cleavage of BID by Caspase 8 Mediates the Mitochondrial Damage in the Fas Pathway of Apoptosis , 1998, Cell.

[45]  K. Schulze-Osthoff,et al.  Role of Reactive Oxygen Intermediates in Activation-induced CD95 (APO-1/Fas) Ligand Expression* , 1998, The Journal of Biological Chemistry.

[46]  S. Krähenbühl,et al.  Canalicular bile flow and bile salt secretion are maintained in rats with liver cirrhosis. Further evidence for the intact cell hypothesis. , 1988, Journal of hepatology.

[47]  T. Chou,et al.  Quantitative analysis of dose-effect relationships: the combined effects of multiple drugs or enzyme inhibitors. , 1984, Advances in enzyme regulation.